Medigen Biotechnology Corp. (TPEX:3176)
Taiwan · Delayed Price · Currency is TWD 32.70
-0.40 (-1.21%)
May 29, 2026, 1:30 PM CST
Medigen Biotechnology Market Cap
Medigen Biotechnology has a market cap or net worth of 4.56 billion as of May 29, 2026. Its market cap has increased by 11.99% in one year.
Market Cap
4.56B
Enterprise Value
6.64B
Revenue
1.34B
Ranking
n/a
PE Ratio
n/a
Stock Price
32.70
Market Cap Chart
Since November 3, 2004, Medigen Biotechnology's market cap has increased from 684.56M to 4.56B, an increase of 565.44%. That is a compound annual growth rate of 9.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2026 | 4.56B | 0.93% |
| Dec 31, 2025 | 4.51B | - |
| Dec 31, 2024 | 4.51B | -27.70% |
| Dec 29, 2023 | 6.24B | 33.24% |
| Dec 30, 2022 | 4.69B | -41.43% |
| Dec 30, 2021 | 8.00B | -2.78% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Mycenax Biotech | 5.66B |
| AnnJi Pharmaceutical | 5.47B |
| ACRO Biomedical | 5.37B |
| Panion & Bf Biotech | 5.17B |
| UnicoCell Biomed | 5.08B |
| Sinew Pharma | 4.78B |
| Steminent Biotherapeutics | 4.63B |
| Pharmosa Biopharm | 4.58B |